← Back to Clinical Trials
Recruiting NCT04477434

NCT04477434 French Observatory of ElectroConvulsive Therapy (ECT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04477434
Status Recruiting
Phase
Sponsor Centre Hospitalier Henri Laborit
Condition Mental Disorders
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2018-04-24
Primary Completion 2027-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2018-04-24 with a primary completion date of 2027-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Since the 30s, ECT has been a psychiatric treatment mainly used for drug-resistant depressive illnesses. Clinical studies have shown its therapeutic efficiency compared to standard treatments also in other psychiatric illnesses. Although efficient, ECTs also induce side effects. In France, there is currently no consensus on providing the suitest medical care. It is therefore important to review our nowadays health care models in order to maintain and improve the recommendations of the French National Agency for Accreditation and Evaluation in Health, the last of which date from 1997! Within this context, this project has the dual objective of (1) identifying ECT medical procedure in France and (2) developing research to evaluate and to improve the effectiveness of this treatment.

Eligibility Criteria

Inclusion Criteria: * Patients consecutively referred for ECT. Exclusion Criteria: * Not specified

Frequently Asked Questions

Who can join the NCT04477434 clinical trial?

This trial is open to participants of all sexes, studying Mental Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04477434 currently recruiting?

Yes, NCT04477434 is actively recruiting participants. Visit ClinicalTrials.gov or contact Centre Hospitalier Henri Laborit to inquire about joining.

Where is the NCT04477434 trial being conducted?

This trial is being conducted at Angers, France, Anglet, France, Avignon, France, Bayonne, France and 11 additional locations.

Who is sponsoring the NCT04477434 clinical trial?

NCT04477434 is sponsored by Centre Hospitalier Henri Laborit. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology